Comparing my results, Dr. Noon CVD's AI-driven retinal scan closely aligned with the CT findings, but in a fraction of the time and without radiation exposure. Many patients receive CAC scores too late and struggle with infrequent testing due to high costs. With Dr. Noon CVD, risk assessments can be repeated more frequently, enabling earlier interventions.

A patient experiencing mild eye pain was unexpectedly diagnosed with severe cardiovascular disease through the Dr. Noon CVD. This early detection led to a life-saving cardiac stent placement. I strongly believe that Dr. Noon CVD will soon become a standard test for the early detection of life-threatening cardiovascular diseases, playing a crucial role in making timely treatment decisions that save lives.